We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Ananda Pharma Plc | AQSE:ANA | Aquis Stock Exchange | Ordinary Share | GB00BDQPXQ60 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.435 | 0.40 | 0.45 | 0.4475 | 0.425 | 0.435 | 666,000 | 15:28:57 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:8509H All Nippon Airways Co Ld 24 February 2003 ANA Revised Forecast for FY2002 ------------------------------------------------------------------------------------------------------------------------ TOKYO, February 24, 2003 - ANA (All Nippon Airways Co., Ltd., TSE9202) today issued revisions to its consolidated and non-consolidated forecasts for FY2002 (April 1, 2002 - March 31, 2003). The revised forecasts replace those originally announced when the results for the first half of FY2002 were reported on November 22,2002. Due to the decrease in domestic passenger revenue caused by severe fare competition and the cost of increased sales promotion to raise demand, ANAfs consolidated operating revenues are expected to be /1,225 billion (previously forecasted / 1,230 billion, as of November 22. 2002), and its operating loss will deteriorate to / 4 billion (previously forecasted operating income / 15billion). Losses are expected to increase with consolidated recurring loss at / 21 billion (previously forecasted / 3 billion loss) and consolidated net loss at / 35 billion (previously forecasted / 18 billion loss). ANAfs consolidated results for the previous year (FY2001) were as follows. Operating Revenue /1,204.5 billion Operating Income /22.9 billion Recurring Income /1.4 billion Net Loss /9.4 billion ANA Three-Year Cost Reduction Plan (FY2003 - FY2005) ------------------------------------------------------------------------------------------------------------------------ Concurrent with the issue of its revised FY2002 forecasts, ANA today announced its cost reduction plan for FY2003 - FY2005 (April 2003 - March 2006). gWe should focus on tackling cost reduction, rather than expecting increased revenue in the recent financial environment of decreased demand and continued deflation,h Executive Vice President Yasushi Morohashi, in charge of both finance and public relations, said. gWe should be able to cut annual operating expenses by /30 billion over the next three yearsh. gWe will aim at decreasing personnel costs by /20 billion, and should realize a further decrease of /10 billion by downsizing aircraft and cutting airport handling costsh he continued. Based on this three-year cost reduction plan, ANA will cut its retirement and pension benefits by around 10%. Agreement already has been reached on the cut with the ANA Workers Union, representing ground personnel and cabin attendants, and talks are now underway with the ANA Crew Association (cockpit crew union). ANA also plans to decrease the number of employees by 1,200 mainly through further improvement of productivity. # # # This information is provided by RNS The company news service from the London Stock Exchange END STRKGGZZLDMGFZG
1 Year Ananda Pharma Chart |
1 Month Ananda Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions